Trulieve Cannabis Corp. quarterly report, Q1 FY2022

Trulieve Cannabis Corp. — Q1 2022 Form 10-Q

Reporting period: Three months ended March 31, 2022; comparative period is Q1 2021. Amounts below are in U.S. dollars. Trulieve is a vertically integrated, multi-state cannabis operator, with most revenue generated from medical cannabis sales in Florida. Q1 results include the expanded business following the October 2021 Harvest acquisition; the company also acquired an Arizona cultivation operation in February 2022.

Financial performance and position

MetricQ1 2022Q1 2021 / comparison
Net revenue$318.3 million$193.8 million; up 64%
Gross profit / margin$178.2 million / 56%$135.3 million / 70%
Operating income$28.7 million$72.6 million
Net income (loss) attributable to common shareholders$(32.0) million; $(0.17) per share$30.1 million; $0.25 per share
Adjusted EBITDA (non-GAAP)$105.5 million$90.8 million; up 16%
Cash provided by operations$45.1 million$59.6 million
Cash used in investing$(83.8) million$(53.4) million
Cash provided by financing$72.2 million$9.5 million
  • Revenue mix: Retail revenue was $290.6 million, versus $181.3 million; wholesale, licensing and other revenue was $27.7 million, versus $12.6 million.
  • Margins and expenses: Cost of goods sold rose 139% to $140.2 million, or 44% of revenue versus 30%. Management attributed the gross-margin decline to increased wholesale sales, higher depreciation, and expansion into markets that are not fully vertically integrated. Sales and marketing was $72.9 million (up 64%); general and administrative expense was $33.5 million (up 164%); depreciation and amortization was $29.3 million (up from $5.4 million).
  • Tax and unusual charges: Income tax expense was $42.3 million on $9.8 million of pretax income, a reported effective rate of 430%. Management cited IRC Section 280E, which limits deductible expenses for cannabis businesses. The quarter included $13.8 million of impairment and disposal losses and $2.7 million of losses on divestment and sale of non-operating assets.
  • Cash and liquidity at March 31: Cash and cash equivalents were $267.2 million, up from $230.6 million at December 31, 2021. Current assets were $593.3 million and current liabilities were $237.8 million. Operating cash flow was lower year over year, in part due to higher working-capital needs, including inventory.
  • Debt and obligations: Private placement notes had $556.9 million of principal outstanding, including $537.7 million net carrying value; other notes payable totaled $13.0 million before discount. The company also reported $139.1 million of operating lease liabilities, $76.1 million of finance lease liabilities and $176.2 million of construction finance liabilities. It issued a further $75.6 million of 8% senior secured notes in January, maturing in October 2026.

Material changes and management commentary

  • Revenue growth reflected retail growth, more products and locations, wholesale expansion, and acquisitions and market expansion; the filing does not quantify the portion attributable to organic growth versus acquisitions.
  • Gross margin fell 14 percentage points. Despite higher revenue and gross profit, operating income declined and the company moved from prior-year net income to a net loss, reflecting margin compression, higher operating costs, increased interest and tax expense, and asset-related losses.
  • Investing cash outflow included $48.1 million of property and equipment purchases, $7.3 million of purchases related to construction finance liabilities, and $27.5 million for the Watkins acquisition. Financing inflow was primarily supported by the additional senior secured notes.
  • Management said existing cash should cover anticipated requirements for at least 12 months from the report’s issuance. It expects to fund future long-term needs, if required, through additional debt, equity financing or both; the filing gives no specific earnings or revenue guidance.
  • Management reported that disclosure controls and procedures were not effective as of March 31, 2022 because previously identified material weaknesses remained under remediation. Remediation efforts included added accounting and reporting personnel, external specialists, IT and process-control improvements, and work on the SAP implementation. Management stated the financial statements fairly present the periods shown, but that further time is needed to complete and assess remediation.

Risks, contingencies and unusual items

  • Cannabis remains illegal under U.S. federal law despite state-level authorization. The filing warns of potential federal enforcement, asset forfeiture, regulatory and licensing risks, and restricted access to banking and bankruptcy protections. The company says substantially all revenue and its balance-sheet exposure relate to U.S. cannabis activities.
  • Section 280E tax treatment can restrict deductions and produce substantial tax expense relative to pretax income. The reported quarterly effective tax rate was unusually high.
  • The company recorded $11.0 million in contingent liabilities related to pending litigation and $1.6 million for estimated sales-tax matters. It also recorded $2.1 million of probable Watkins acquisition earnout liabilities. The filing states no pending or threatened lawsuit was expected to have a material effect on results.
  • The company temporarily idled the acquired Alachua cultivation facility and was evaluating its future use while remaining in compliance with the related lease. Southeast asset repositioning contributed to the quarter’s impairment and disposal charges.
  • Other stated risks include acquisition and integration execution, competition, growth and capital requirements, regulatory change, product and operational risks, and the company’s significant indebtedness. The filing reported no material change to the risk factors in its 2021 Form 10-K.

Investor verification priorities

  1. Assess how much of reported revenue growth reflects acquisitions and added locations versus comparable-store or other organic growth, and whether the lower gross margin persists.
  2. Review the drivers and sustainability of the $42.3 million tax provision, the 430% effective rate, and the impact of Section 280E.
  3. Verify the company’s debt-service capacity, cash needs for capital investment and leases, and compliance with senior-note covenants.
  4. Track cash conversion and working-capital needs, particularly inventory growth, alongside capital expenditure plans.
  5. Monitor remediation and independent assessment of the material weaknesses in internal control and disclosure controls.
  6. Follow the Alachua facility’s future use, asset-repositioning charges, and the status of litigation, sales-tax and Watkins earnout contingencies.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.